SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000904454-13-000863
Filing Date
2013-07-31
Accepted
2013-07-31 17:47:24
Documents
1
Period of Report
2013-07-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4/A  
1 PRIMARY DOCUMENT edgar.xml 4/A 3459
  Complete submission text file 0000904454-13-000863.txt   5110
Mailing Address 12651 HIGH BLUFF DRIVE SUITE 230 SAN DIEGO CA 92130
Business Address 12651 HIGH BLUFF DRIVE SUITE 230 SAN DIEGO CA 92130 858-436-3900
Ocera Therapeutics, Inc. (Issuer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address ONE PALMER SQUARE PRINCETON NJ 08542
Business Address ONE PALMER SQUARE PRINCETON NJ 08542 (609) 683-5656
Domain Partners VI, L.P. (Reporting) CIK: 0001298033 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4/A | Act: 34 | File No.: 001-35119 | Film No.: 131000189